These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35302756)

  • 21. The Synergy between CRISPR and Chemical Engineering.
    Lau CH; Tin C
    Curr Gene Ther; 2019; 19(3):147-171. PubMed ID: 31267870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
    Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
    Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9 based plant genome editing: Significance, opportunities and recent advances.
    Soda N; Verma L; Giri J
    Plant Physiol Biochem; 2018 Oct; 131():2-11. PubMed ID: 29103811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9-mediated targeted mutagenesis of GmSPL9 genes alters plant architecture in soybean.
    Bao A; Chen H; Chen L; Chen S; Hao Q; Guo W; Qiu D; Shan Z; Yang Z; Yuan S; Zhang C; Zhang X; Liu B; Kong F; Li X; Zhou X; Tran LP; Cao D
    BMC Plant Biol; 2019 Apr; 19(1):131. PubMed ID: 30961525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells.
    Banan M
    J Biotechnol; 2020 Jan; 308():1-9. PubMed ID: 31751596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Applications of CRISPR/Cas9-Based Genome Editing in
    Mu Y; Zhang C; Li T; Jin FJ; Sung YJ; Oh HM; Lee HG; Jin L
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361647
    [No Abstract]   [Full Text] [Related]  

  • 27. CRISPR activation and interference as investigative tools in the cardiovascular system.
    Carroll MS; Giacca M
    Int J Biochem Cell Biol; 2023 Feb; 155():106348. PubMed ID: 36563996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boosting targeted genome editing using the hei-tag.
    Thumberger T; Tavhelidse-Suck T; Gutierrez-Triana JA; Cornean A; Medert R; Welz B; Freichel M; Wittbrodt J
    Elife; 2022 Mar; 11():. PubMed ID: 35333175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of potential applications of repurposed Cas9 for structural and functional genomics of plants.
    Seth K; Harish
    Biochem Biophys Res Commun; 2016 Nov; 480(4):499-507. PubMed ID: 27955725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances of CRISPR/dCas9 system in live cell imaging].
    Lin S; Zhong X; Ma L; Qiao J; Liu Y
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3061-3070. PubMed ID: 34622617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid and reversible epigenome editing by endogenous chromatin regulators.
    Braun SMG; Kirkland JG; Chory EJ; Husmann D; Calarco JP; Crabtree GR
    Nat Commun; 2017 Sep; 8(1):560. PubMed ID: 28916764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new normal of structure/function studies in the era of CRISPR/Cas9.
    Logsdon GA; Black BE
    Biochem J; 2018 May; 475(9):1635-1642. PubMed ID: 29764955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
    Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
    Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
    Hillary VE; Ceasar SA
    Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted genome regulation via synthetic programmable transcriptional regulators.
    Piatek A; Mahfouz MM
    Crit Rev Biotechnol; 2017 Jun; 37(4):429-440. PubMed ID: 27093352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Act3.0-Based Highly Efficient Multiplexed Gene Activation in Plants.
    Pan C; Qi Y
    Curr Protoc; 2022 Feb; 2(2):e365. PubMed ID: 35157372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidimensional chemical control of CRISPR-Cas9.
    Maji B; Moore CL; Zetsche B; Volz SE; Zhang F; Shoulders MD; Choudhary A
    Nat Chem Biol; 2017 Jan; 13(1):9-11. PubMed ID: 27820801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.